Log In
Print
BCIQ
Print
Print this Print this
 

ALZ-101

  Manage Alerts
Collapse Summary General Information
Company Alzinova AB
DescriptionAmyloid beta 42 oligomer
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPeptide
Latest Stage of DevelopmentDiscovery
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today